Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

NCT06393452 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia

Interventions

DRUG: PP405 0.05% Topical Gel
DRUG: PP405 Topical Vehicle Gel

Sponsor

Pelage Pharmaceuticals, Inc.